Restore Mind Medicine

Trial Diagram Male and female eligible patients aged ≥ 18 and ≤ 70 years with GAD either previously diagnosed or diagnosed at screening who agree to participate in the study. Arm 1 25 μg MM-120×2 doses GAD Patients Arm 2 50 μg MM-120 x2 doses 6 weeks Treatment Effect Final patient follow up visit Arm 3 100 µg MM-120 x2 doses 63

View entire presentation